4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-053559
Chairman and CEO bought 165,000 shares at an average $0.08 ($13,250)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-10-11 | Purchase | +5,000 | $0.09 | $450 | 11,523,857 | D |
| Niihara Yutaka Chairman and CEO | 2022-10-12 | Purchase | +160,000 | $0.08 | $12,800 | 11,683,857 | D |
| Open-market purchases · 165,000 sh · avg $0.08 · $13,250 | |||||||
Loading xslF345X03/doc4.xml…